Skip to main content
. 2020 Aug 17;12(8):2318. doi: 10.3390/cancers12082318

Figure 2.

Figure 2

For early GC, the 5-year OS rates (89.1% vs. 80.8%, p = 0.027) were significantly better for patients with SRC than those without SRC. For advanced GC, the five-year OS rates (41.3% vs. 52.1%, p = 0.036) were significantly worse for patients with signet-ring cell carcinoma (SRC) than those without SRC. (A) OS curves of early GC patients with and without SRC; (B) OS curves of advanced GC patients with and without SRC.